Guillermo Garcia-Manero, MD
Professor, Department of Leukemia, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes, Department of Leukemia, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, characterizes the clinical outcome improvements observed with luspatercept for lower-risk myelodysplastic syndromes in clinical practice.
Supported through funding by
To sign up for our newsletter or print publications, please enter your contact information below.
Subscribe to recieve the free, monthly TON print publication and TON weekly e‑newsletter.